| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9680 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8244 |
| P-glycoprotein Substrate | Substrate | 0.6387 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7638 |
| Inhibitor | 0.5835 |
| Renal Organic Cation Transporter | Inhibitor | 0.5432 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6517 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7296 |
| CYP450 2D6 Substrate | Substrate | 0.7982 |
| CYP450 3A4 Substrate | Substrate | 0.6072 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8393 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8564 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8322 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8767 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.8256 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7992 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.6633 |
| Inhibitor | 0.8548 |
| AMES Toxicity | Non AMES toxic | 0.6571 |
| Carcinogens | Non-carcinogens | 0.7622 |
| Fish Toxicity | High FHMT | 0.9635 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9642 |
| Honey Bee Toxicity | High HBT | 0.5149 |
| Biodegradation | Not ready biodegradable | 0.9921 |
| Acute Oral Toxicity | III | 0.7662 |
| Carcinogenicity (Three-class) | Non-required | 0.7175 |